Creating a small animal model to study Lassa virus infections and test treatments.
Task A02: Development of Small Animal Lassa Virus infection Model for the Assessment of Anti-Viral Activity of Medical Countermeasures Efficacy
This study is working on creating better animal models to learn more about Lassa virus infections, which could help find new treatments and ways to prevent Lassa fever that might benefit patients in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-11197631 on NIH RePORTER |
What this research studies
This research focuses on developing and refining small animal models to better understand Lassa virus infections. By simulating the disease in these models, researchers aim to evaluate the effectiveness of potential medical countermeasures against the virus. Patients may benefit indirectly from this work as it could lead to improved treatments and preventive measures for Lassa fever. The approach involves rigorous testing and assessment of antiviral activities in controlled environments.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research would be individuals at risk of Lassa fever or those living in endemic regions.
Not a fit: Patients who are not at risk for Lassa fever or who do not live in areas where the virus is prevalent may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments for Lassa fever, improving patient outcomes.
How similar studies have performed: Other research has shown success in developing animal models for viral infections, indicating that this approach has potential for yielding valuable insights.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Beasley, David — University of Texas Med Br Galveston
- Study coordinator: Beasley, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.